Incannex Healthcare Inc.

Q4-CY2025

Q3-CY2025

Q2-CY2025

Q1-CY2025

Q4-CY2024

Q3-CY2024

Q2-CY2024

Q1-CY2024

Q4-CY2023

Q3-CY2023

Q2-CY2023

Q1-CY2023

Q4-CY2022

Q3-CY2022

Q2-CY2022

Q1-CY2022

Q4-CY2021

Q3-CY2021

Q2-CY2021

Q1-CY2021

Q4-CY2020

Q3-CY2020

Q2-CY2020

Q1-CY2020

Q4-CY2019

Q3-CY2019

Q2-CY2019

Q1-CY2019

Q4-CY2018

Q3-CY2018

Q2-CY2018

Q1-CY2018

Q4-CY2017

Q3-CY2017

Q2-CY2017

Q1-CY2017

Q4-CY2016

Q3-CY2016

Q2-CY2016

Q1-CY2016

Q4-CY2015

Q3-CY2015

Q2-CY2015

Q1-CY2015

Q4-CY2014

Q3-CY2014

Q2-CY2014

Q1-CY2014

Q4-CY2013

Balance Sheet Date

2025-Jun-30

2025-Mar-31

2024-Dec-31

2024-Sep-30

2024-Jun-30

2024-Mar-31

2023-Dec-31

Fiscal Period

Q4-FY2025

Q3-FY2025

Q2-FY2025

Q1-FY2025

Q4-FY2024

Q3-FY2024

Q2-FY2024

Operating Cash Flow

(1,482,000$)

(3,159,000$)

(5,679,000$)

(2,193,000$)

(3,642,000$)

(4,351,000$)

(5,749,000$)

(2,582,000$)

(2,730,000$)

Investing Cash Flow

0$

0$

(3,000$)

6,000$

(221,000$)

(171,000$)

(32,000$)

Financing Cash Flow

9,602,000$

7,744,000$

4,102,000$

(52,000$)

(32,000$)

(73,000$)

End Cash Position

15,039,000$

6,711,000$

2,098,000$

3,627,000$

5,858,000$

9,305,000$

14,554,000$

16,278,000$

22,120,000$

24,880,000$

28,065,000$

Exchange Rate Effect

208,000$

28,000$

198,000$

(905,000$)

26,000$

(350,000$)

Dividends Paid

• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation